| Literature DB >> 22157680 |
Anette Schneider1, Christian Thiel, Jan Rindermann, Charles DeRossi, Diana Popovici, Georg F Hoffmann, Hermann-Josef Gröne, Christian Körner.
Abstract
Congenital disorder of glycosylation-Ia (CDG-Ia, also known as PMM2-CDG) is caused by mutations in the gene that encodes phosphomannomutase 2 (PMM2, EC 5.4.2.8) leading to a multisystemic disease with severe psychomotor and mental retardation. In a hypomorphic Pmm2 mouse model, we were able to overcome embryonic lethality by feeding mannose to pregnant dams. The results underline the essential role of glycosylation in embryonic development and may open new treatment options for this disease.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22157680 DOI: 10.1038/nm.2548
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440